Immunomagnetic separation technologies

Recent Results in Cancer Research

Volumn 195, Issue , 2012, Pages 43-58

  Hoeppener, Astrid E L M ^a   Swennenhuis, Joost F ^a   Terstappen, Leon W M M ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Circulating tumor cells; CTC detection; CTC enrichment; Ferrofluids

Indexed keywords

CYTOKERATIN; SOMATOMEDIN C RECEPTOR;

ARTICLE; CELL ASSAY; CELL SELECTION; CELL SEPARATION; CIRCULATING TUMOR CELL; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; PATIENT MONITORING; PRIORITY JOURNAL; SEPARATION TECHNIQUE;

FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; MICROSCOPY, FLUORESCENCE; NEOPLASTIC CELLS, CIRCULATING;

EID: 84860548373     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-28160-0_4     Document Type: Article

References (77)

1. Recamier JCA (1829) L'histoire de le Meme Maladie. Gabor 1829:110
2. Ashworth TR (1869) A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australian Med J 14:146-147
3. Engell HC (1955) Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl 201:1-70
4. Carey RW, Taft PD, Bennett JM et al (1976) Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells. Am J Med 60(2):273-278
5. Myerowitz RL, Edwards PA, Sartiano GP (1977) Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast: report of a case. Cancer 40(6):3107-3111
6. Gallivan MV, Lokich JJ (1984) Carcinocythemia (carcinoma cell leukemia). Report of two cases with English literature review. Cancer 53(5):1100-1102 (Pubitemid 14196489)
7. Yam LT, Janckila AJ (1987) Immunocytodiagnosis of carcinocythemia in disseminated breast cancer. Acta Cytol 31(1):68-72 (Pubitemid 17010983)
8. Sile CC, Perry DJ,Nam L (1999) Small cell carcinocythemia. Arch Pathol LabMed 123(5):426-428 (Pubitemid 29215397)
9. Seronie-Vivien S, Mery E, Delord JP et al (2001) Carcinocythemia as the single extension of breast cancer: report of a case and review of the literature. Ann Oncol 12(7):1019-1022 (Pubitemid 32725780)
10. Salsbury AJ (1975) The significance of the circulating cancer cell. Cancer treatment review 2:55
11. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe A, Uhr JW, Terstappen LWMM (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin Can Res 10:6897-6904 (Pubitemid 39383039)
12. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Rueben JM, Doyle G, Allard WJ, Terstappen LWMM, Hayes DF (2004) Circulating tumor cells, disease progression and survival in metastatic breast cancer. NEJM 351:781-791 (Pubitemid 39095313)
13. Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Christopher E. Desch, Miller MC, Doyle GV, Tissing H, Terstappen LWMM, MeropolNJ (2008)The relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. JCO 26:3213-3221
14. DeBono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LWMM, Pienta KJ, Raghavan D (2008) Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC). Clin Can Res 14:6302-6309
15. Coumans F, Doggen CJM, Attard G, de Bono JS, Terstappen LWMM (2010) All circulating EpCAM ? CD45-CK ? but not EpCAM ? CD45 ? CK ? objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 21:1851-1857
16. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K (2007) Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the cell search system. Clin Cancer Res 13:920
17. Yagata H, Nakamura S, Toi M, Bando H, Ohno S, Kataoka A (2008) Evaluation of circulating tumor cells in patients with breast cancer: multi-institutional clinical trial in Japan. Int J Clin oncol 13:252-256 (Pubitemid 351871893)
18. Bidard FC, Mathiot C, Delaloge S, Brain E, Giachetti S, de Cremoux P, Marty M, Pierga JY (2010) Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol 21:729-733
19. Shaffer DR, Leversha MA, Danila DC et al (2007) Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 13:2023-2029 (Pubitemid 46649868)
20. Liu MC, Shields PG, Warren RD, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong J, Seillier-Moiseiwitsch F, Noone AM, Claudine Isaacs C (2009) Circulating Tumor Cells: a useful predictor of treatment efficacy in metastatic breast cancer. JCO 27(31): 5153-5159
21. Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R, Kasimir-Bauer S (2009) Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 11:R59
22. Matsusaka S, Chý'n K, Ogura M, Suenaga M, Shinozaki E, Mishima Y, Terui Y, Mizunuma N, Hatake K (2010) Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 101(4):1067-1071
23. Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A, Ward TH, Ferraldeschi R, HughesA,Clack G,RansonM,Dive C, BlackhallFH(2011) Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. JCO 29(12):1558-1563
24. Lin H, Balic M, Zheng S, Datar R, Cote RJ (2011) Disseminated and circulating tumor cells: role in effective cancer management. Crit Rev Oncol Hematol 77:1
25. Mostert B, Sleijfer S, Foekens J, Gratama JW (2009) Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35:463
26. Liu Z, Fusi A, Klopocki E, Schmittel A, Tinhofer I, Nonnenmacher A, Keiholz U (2011) Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients. J transl med 9:70
27. Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, Zborowski M, Chalmers JJ (2009) Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 102:521-534
28. Alix-Panabieresa C, Brouillet JP, Fabbroe M, Ysself H, Rousset T, Maudelondec T, Choquet- Kastylevsky G, Vendrella JP (2005) Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. J Immunol Methods 299:177-188 (Pubitemid 40725934)
29. Okarma T, Lebkowski J, Schain L, Harvey M, Tricot G, Srour E, Meyers WG, Burnett A, Sniecinski I, O'Reilly RJ (1992) The AIS CELLector: a new technology for stem cell purification. Prog Clin Biol Res 377:487-502
30. Yuan J, Rubin E, Aljurf M, Ma L, Schrier SL (1994) Defective assembly of membrane proteins in erythroid precursors of beta-thalassemic mice. Blood 84:632-637
31. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MH, Chen LB, Lerner RA, Bruce RH (2004) A rare-cell detector for cancer. PNAS 101:10501-10504 (Pubitemid 38955770)
32. Rao C, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA, Terstappen LWMM (2005) Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncology 27:49-58
33. Gross HJ, Verwer B, Houck D, Hoffman RA, Recktenwald D (1995) Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10-7. Proc Natl Acad Sci U S A 92:537-541
34. Punnoose EA, Atwal SK, Spoerke JM, Savage A, Pandita A, Yeh RF, Pirzkall A, Fine BM, Amler LC, Chen DS, Lackner MR (2010) Molecular biomarker analyses using circulating tumor cells. PLoS ONE 5:e12517
35. ObermayrE, Sanchez-Cabo F,TeaMKM,SingerCF, KrainerM,FischerMB,Sehouli J, Reinthaller A,Horvat R, Heinze G, Tong D, ZeillingerR(2010)Assesment of a six gene panel for themolecular detection of circulating tumor cells in blood of female cancer patients. BMC cancer 10:666
36. Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou ES, Georgoulias V, Mavroudis D, Agelaki S (2009) Hypoxia-inducible factor-1a and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 11:R85
37. Halabi S, Small EJ, Hayes DF, Vogelzang HN, Kantoff PW (2003) Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB9583. JCO 21:490-495 (Pubitemid 46606479)
38. Rosenberg R, Gertler R, Friederichs J et al (2002) Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 49:150
39. Schwartz R, Walk A, Toomes H, Schirrmacher V (1985) Assay for the determination of human carcinoma cells in circulating blood. J Cancer Res Clin Oncol 109:122-129 (Pubitemid 15145341)
40. Lara O, Tong X, Zborowski M, Chalmers JJ (2004) Enrichment of rare cancer cells through depletion of normal cellsusing density and flow-through immunomagnetic cell separation. Exp Hematol 32:891-904 (Pubitemid 39410703)
41. He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, Low PS (2008) Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer 123:1968-1973
42. Lin HK, Zheng S, Williams AJ (2010) Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 16:5011
43. Zheng S, Lin HK, Lu B, Williams A, Cote RJ, Tai Y (2011) Microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed microdevices 13:203
44. Swee JT, Qingsen L, Chwee TK (2010) Manipulation and isolation of single cells and nuclei. Methods Cell Biol 98:79
45. Wang X, Yang J, Huang Y, Vykoukal J, Becker FF, Gascoyne PRC (2010) Cell separation by dielectrophoretic field-flow-fractionation. Anal Chem 72:832
46. Stahel RA, Gilks WR, Lehmann HP, Schenker T (1994) Third international workshop on lung tumor and differentiation antigens: overview of the results of the central analysis. Int J Cancer 8(Suppl):6-26 (Pubitemid 24188951)
47. Momburg F, Moldenhauer G, Hammerling GJ, Moller P (1987) Immunohistochemical study of the expression of a Mr 34,000 human epithelium specific surface glycoprotein in normal and malignant tissues. Cancer Res 47:2883-2891 (Pubitemid 17113431)
48. Balzar M, Winter MJ, de Boer CJ, Litvinov SV (1999) The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77:699-712
49. Went P, Vasei M, Bubendorf L, Terracciano L, Tornillo L, Riede U, Kononen J, Simon R, Sauter G, Baeuerle PA (2006) Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br J Cancer 94:128-135 (Pubitemid 43088552)
50. Kagan M, Howard D, Bendele T, Mayes J, Silvia J, Repollet M, Doyle J, Allard J, Tu N, Bui T, Russell T, Rao C, Hermann M, Rutner H, Terstappen LWMM(2002) A sample preparation and analysis system for identification of circulating tumor cells. J Clinical Ligand Assay 25:104-110 (Pubitemid 34984736)
51. Tibbe AGJ, de Grooth BG, Greve J, Dolan GJ, Rao C, Terstappen LWMM (2002) Magnetic field design for selecting and aligning immunomagnetic labeled cells. Cytometry 47:163-172 (Pubitemid 34242029)
52. Kagan M, Trainer M, Bendele T, Rao C, Horton A, Tibbe A, Greve J, Terstappen LWMM (2002) CellTracks cell analysis system for rare cell detection. In: Cohn GE (ed), Clinical diagnostic systems: technologies and instrumentation 4625:20-28 (Pubitemid 35220542)
53. Liberi PA, Rao CG, Terstappen LWMM (2001) Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magn Magn Mater 225:301-307 (Pubitemid 32335309)
54. Saliba AE, Saias L, Psychari E, Minc N, Simon D, Bidard FC, Mathiot C, Pierga JY, Fraisier V, Salamero J, Saada V, Farace F, Vielh P, Malaquin L, Viovy JL (2010) Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. PNAS 107:14524
55. Jost M, Day JR, Slaughter R, Koreckij TD, Gonzales D, Kinnunen M, Groskopf J, Rittenhouse HG, Vessella RL, Reynolds MA (2010) Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood. Mol Cancer 9:174
56. Cheung LS, Zheng X, Wang L, Baygents JC, Guzman R, Schroeder JA, Heimark RL, Zohar Y (2011) Adhesion dynamics of circulating tumor cellsunder shear flow in a bio-functionalized microchannel. J Micromech Microeng 21:1
57. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak El, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M (2007) Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature Letters 450:1235
58. Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF (2008) Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 10:R69
59. Terstappen LWMM (2000) Detection of infrequent cells in blood and bone marrow by flowcytometry. In:Ho A., Haas R, Champlin RE (ed) Hematopoietic stem cell transplantation. Marcel Dekker Inc., New York pp 137-152. http://books.google.nl/books?id=of5opeaV-OsC& printsec=frontcover&hl= nl&source=gbs-ge-summary-r&cad=0#v=onepage&q&f=false
60. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW (1998) Detection and characterization of carcinoma cells in the blood. PNAS 95:4589-4594 (Pubitemid 28207957)
61. Méhes G, Witt A, Kubista E, Ambros PF (2001) Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159:17
62. Müller V, Stahmann N, Riethdorf S et al (2005) Circulating tumor cells in breast cancer: correlation to bone marrow micrometastasis, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11:3678
63. Rao C, Rutner H, Hermann M, Russell T, Terstappen LWMM (2002) Preservation of blood specimens to prevent breakdown of circulating tumor cells. Proc Am Assoc Cancer Res 43:734
64. Allard WJ, Hayes DF, Repollet MI et al (2003) A cellular preservative improves the specificity and yield of circulating tumor cells in carcinoma patients [abstract A3482]. Proc Am Soc Clin Oncol 22:866
65. Terstappen LWMM, Loken MR (1988) 5 dimensional flow cytometry as a new approach for blood and bone marrow differentials. Cytometry 9:548-556 (Pubitemid 18264737)
66. LarsonCJ,Moreno JG, PientaKJ,Gross S,RepolletM,O'Hara SM,RussellT,TerstappenLWMM (2004) Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry 62A:46-53 (Pubitemid 39473452)
67. TerstappenLWMM,Rao C,Gross S,WeissA(2000) Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol 17:573-578
68. Terstappen LWMM, Rao GC, Liberti PA (2003) Increased separation efficiency via controlled aggregation of magnetic nanoparticles. United States Patent 6, 620, 627 B1
69. Rao C, Bui T, Connelly M, Doyle G, Karydis I, Middleton MR, Clack G, Malone M, Coumans F, Terstappen LWMM (2011) Circulating melanoma cells and survival in metastatic melanoma. Int. J. Oncology 38:755-760
70. Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, Connely MC, Rao C, Terstappen LWMM (2007) Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry part A 71A:105-113 (Pubitemid 46238939)
71. O'Hara SM, Moreno JG, Zweitzig DR, Gross G, Gomella LG, Terstappen LWMM (2004) Multigene reverse transcription-PCR profiling of circulating tumor cells in hormonerefractory prostate cancer. Clin Chem 50:826-835 (Pubitemid 38543661)
72. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connely MC, Terstappen LWMM, O'Hara SM (2005) Global gene expression profiling of circulating tumor cells. Cancer Res 65:4993-4997 (Pubitemid 40827303)
73. Tibbe AGJ, Miller C, Terstappen LWMM (2007) Statistical considerations for enumeration of circulating tumor cells. Cytometry Part A 71A:154-162 (Pubitemid 46355340)
74. Kraan J, Sleijfer S, StrijbosM, IgnatiadisM, PeetersD, Pierga JY, Farace F,Riethdorf S, FehmT, ZorzinoL,TibbeAGJ,MaestroM,Gisbert-CriadoR,DentonG,DeBono JS, Dive C, Foekens JA, Gratama JW(2011) Eternal quality assurance of circulating tumor cell enumeration using the cell search( ) system: a feasibility study. Cytometry B 80B(2):112-118
75. Ligthart SJ, Coumans FAW, Attard G, Mulick CA, de Bono JS, Terstappen LWMM (2011) Unbiased and automated identification of a circulating tumour cell definition that associates with overall survival. PLoS ONE 6(11):e27419. doi:10.1371 2011
76. De Bono JS, Attard G, Adjei A, Pollak MN, Fong PC, Haluska P, Roberts L, Melvin C, Repollet M, Chianese D, Connely M, Terstappen LWMM, Gualberto A (2007) Potential Applications for Circulating Tumor Cells expressing the insulin Growth-Factor-I Receptor. Clin Can Res 13:3611-3616 (Pubitemid 46955123)
77. Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Gualberto A (2009) Safety, pharmacokinetics and pharmacodynamics of the IGF-IR inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin. J Thorac Oncol 4(11):1397-1403